Nephrology Videos
Advertisement
Carla Nester spoke about two presentations at Kidney Week focused on potential therapies for C3 glomerulopathy.
Sagar Nigwekar discussed interim data from the SEAPORT 1 trial of INZ-701 for treatment of calciphylaxis.
Jesse Goodrich and Hailey Hampson spoke about their study of the connection between PFAS, the gut, and kidney function.
Guru Reddy discussed three posters presented by Unicycive Therapeutics at ASN Kidney Week 2024, on UNI-494 and OLC.
Jonathan Barratt discussed advances in IgA nephropathy treatment with Joel Topf at ASN Kidney Week 2024.
Susan Quaggin, winner of the 2024 John P. Peters Award, spoke with us about the award, her work, and ASN Kidney Week.
Melissa Little discussed kidney regeneration and her stem cell research with Joel Topf of Nephrology Times.
Mohamad Hussain spoke with us about a phase 3 trial of the acellular tissue engineered vessel in AV access for hemodialysis.
After their poster tour at ASN Kidney Week 2024, Roger Rodby and Edgar Lerma shared a few highlights with Joel Topf.
Katherine Tuttle spoke with Joel Topf about FLOW trial results presented at ASN Kidney Week 2024.
Hiddo Heerspink discussed his Kidney Week presentations on SC0062 for IgAN and semaglutide in obesity with nondiabetic CKD.
Jonathan Barratt discussed his research on the anti-APRIL antibody sibeprenlimab in the treatment of IgA nephropathy.
Abdul Abdellatif discussed findings from the PROTECT study examining pegloticase for kidney transplant patients with gout.
Dr. Benjamin Dekel shared insights on kidney regenerative medicine with Nephrology Times.
Michael Spigler of the American Kidney Fund spoke with Nephrology Times about the Unknown Causes of Kidney Disease Project.
ANNA's national president spoke about its support for nephrology nurses and the upcoming 2024 Nephrology Nursing Summit.
Hilary Hatch discussed a survey finding that patient-provider conversations and patient activation play a key role in CKD.
Dr. Charles Vega spoke with Nephrology Times about the disproportionate chronic kidney disease burden among Latinos.
Anjay Rastogi, MD, PhD, spoke about findings from the ZORA study regarding the efficacy of SZC for hyperkalemia.
The co-directors of Stanford's NephroNICU Program spoke about their unique program.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.